Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. - Wikidata - awgldk - TriplyDB

Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

http://www.wikidata.org/entity/Q33724815

about

Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.Nonalcoholic fatty liver disease - A multisystem disease?Controversies in the Diagnosis and Management of NAFLD and NASH.Nonalcoholic fatty liver disease and cardiovascular disease Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.Risk factors for fatty liver in the Multicenter AIDS Cohort Study.CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY.Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity.Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis.Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study.Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.Amelioration of lipid abnormalities by vitamin therapy in women using oral contraceptives Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.Normal weight dyslipidemia: Is it all about the liver?Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States.The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus.Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease.Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis

P2860

Q26827665-3E32B9BA-F1EB-49CF-934D-B9F704FEF305 Q27692035-61455389-43C3-4880-A4FB-0DDC01540E78 Q28079077-E2BE5E48-B306-4E1E-9539-80DACF45077E Q30412296-9D84E60D-7B25-4554-A0DF-3C2C7E518FA2 Q33886952-B83EBF63-1ED6-49F9-B7BB-51254446C1DA Q33932951-D796067F-C0CE-4E91-B1BE-CD3E9344A8E6 Q34011629-D1FE9CE8-A123-4685-BC67-D823D27197F7 Q34049896-E322DCFB-160A-40F2-8CFE-349D58ED5FFA Q34680490-36687090-4F12-4453-8CF1-1150A683F111 Q34907809-9856A9DF-7EC9-4D88-9F72-F16A77B20F37 Q35004571-B5A41644-D16F-487D-9406-160DE8939D46 Q35395228-5CDE20D8-0FB7-4CC7-8A7B-F739EE401EE3 Q35582273-FC5BD446-D48E-47E5-84BD-32EC78A465F7 Q35589319-4FAEDEA6-5B34-4A7D-A2D8-4BB25C58B513 Q35716357-C8966E73-9962-4350-A738-D75CE4AE2945 Q35850407-7F3651E0-A04E-410E-9FD6-D092DC33A12A Q35903742-EC21FD1B-3B50-47DE-B804-C27373E667C2 Q36496717-4D705024-155D-4E8E-A879-4B4BFD4F2F59 Q36599680-55459AD4-2805-4A4B-B1D4-3CB7376D8A98 Q36905761-8542ADDD-E1DA-4DEF-96A3-F5BBD6DDACF3 Q37088653-6E3A6626-19FC-4E36-B97A-1CC2E85A9279 Q37411158-5180EBF0-8DE4-4D1D-86D1-AB572613CC4C Q37517243-14C02096-1397-4FD8-93DE-9DDC8CCFA581 Q37548563-A0AE9D4F-41AB-498A-8D5B-85D43F8CAEBC Q37596189-357634B3-9131-4C41-8F6C-D49D641FD4F1 Q37633361-F91A472A-08C1-45D6-94E4-329E77280809 Q37669751-70BCC73F-6E5C-4C44-A78B-82FA59A84938 Q37705810-63EE5B6A-A1A4-4327-8963-4706D91E498A Q38580885-96FE5D84-D5E8-4FB4-9EE5-AD5FC3570030 Q38730392-C9C72137-D5E1-4DA1-8B2F-021484CE744B Q41706857-1A463BED-6281-4A4D-A681-1FDCEEAB4500 Q41722812-4586AAA6-49C2-4A42-8A92-57DCD658B5C1 Q45408801-5ADD58C2-7B65-4E83-938A-BA0D46C36E23 Q47131162-32FBC06C-EC15-48FE-A78D-CD4B3E4EE1A4 Q55266683-05A5AC88-B021-4482-AE12-15B84B3D6E57 Q58731134-C7E4D3DE-C231-4AD5-83F4-2E7FB1403BD5 Q58802369-35FEA0AF-CF23-450F-8905-8F341D024D20

P2860

Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.

http://www.wikidata.org/entity/Q33724815

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@ast

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@en

type

label

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@ast

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@en

prefLabel

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@ast

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@en

P1433

Q33724815-08195F2B-803D-4AB4-BF59-E0064991EA4C

P1476

Q33724815-5E54CDE0-CF54-4AFC-AA17-5A0F090CE8CB

P2093

Q33724815-39D7B6F0-C7F1-49C8-98B2-E3732D422F2D

Q33724815-65A03E25-6A5B-4F0C-A856-4C61B00816DB

Q33724815-86DD6FDF-7948-4E11-A187-C233655D91F1

Q33724815-AEE09026-A24F-4B82-8189-DED96A3BB5DC

Q33724815-D3ABE42E-2141-4D07-8D9F-A52786551030

Q33724815-FBA7496D-3F06-4663-8EEE-62565BFEA3DC

P2860

Q33724815-03781E47-A899-43DD-933B-198C25511495

Q33724815-0E24A72F-1B47-46E1-A7AF-A4AA26B6D389

Q33724815-0EFA9179-7C7E-4D3A-A622-31E199697FC3

Q33724815-2328F0DE-B41E-4E68-B959-2FAB97B2C753

Q33724815-23308EB1-B9D8-4D0D-9C05-3356C11A6AF2

Q33724815-23BC1A5F-A654-4C01-9C99-4CE42511A053

Q33724815-276EE11A-CACE-44B5-8D35-0CF79F7D8218

Q33724815-2F3BC519-E273-469B-8ACF-A1184B01E96A

Q33724815-32D9BE72-331C-4600-871B-01E0D1F8D030

Q33724815-33B2A6DE-2547-4BBD-86D0-8121F1483F8B

P304

Q33724815-BAA6F6EB-0944-4BF3-BABE-A3AAF50D300F

P31

Q33724815-D3E5158C-0C6D-4897-BADA-A515E2903E36

P356

Q33724815-3EFBDC48-6EC1-4CDC-A0B5-B3A55E7C2202

P433

Q33724815-6BAECB97-62FD-4CA7-88E8-6B8E441F6761

P478

Q33724815-68FCAC69-2A2A-48F9-9F8B-286936F958CA

P50

Q33724815-B455DEDC-7678-4031-9350-5E20C7691B4A

Q33724815-CDF62D82-A75F-4058-8C57-AB60F0221051

P577

Q33724815-EC4E4AB3-EB87-4951-B336-18D85D4B22EE

P5875

Q33724815-11DB0876-70AF-4371-916B-48EBB109C160

P698

Q33724815-B0B78A0E-2646-49D5-8EDD-03E6F189F1E3

P921

Q33724815-487553A4-C7AA-46EB-B12F-48D88BFA4845

P932

Q33724815-56B3B106-E8BF-4737-A965-24FB9F0AB9FD

P356

J.ATHEROSCLEROSIS.2013.01.022

P1433

Atherosclerosis

P1476

Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.

@en

P2093

Andrew Paul DeFilippis

http://www.w3.org/2001/XMLSchema#string

Michael J Blaha

http://www.w3.org/2001/XMLSchema#string

Robert M Reed

http://www.w3.org/2001/XMLSchema#string

Roger S Blumenthal

http://www.w3.org/2001/XMLSchema#string

Seth S Martin

http://www.w3.org/2001/XMLSchema#string

Steven R Jones

http://www.w3.org/2001/XMLSchema#string

P2860

LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

Multi-Ethnic Study of Atherosclerosis: objectives and design

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.

Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

P304

429-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2013.01.022

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

227

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J Budoff

P577

2013-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235657855

http://www.w3.org/2001/XMLSchema#string

P698

23419204

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4049078

http://www.w3.org/2001/XMLSchema#string